Molecular Imaging of Neurodegenerative Disorders

Donna Cross, PhD is an Associate Professor in the department of Radiology and Imaging Sciences at the University of Utah with 20 years experience using neuroimaging to study neurodegenerative disease and CNS disorders. Her goal is to make a significant impact on therapeutic and diagnostic options for neurological disorders through imaging. Dr. Cross' research focuses on the innovative use of imaging technology to provide a translational bridge between bench top and patient, and to advance biological discovery though novel applications of imaging and data analysis. She was the Associate Chair for Scientific Abstracts for the Scientific Program Committee of the Society of Nuclear Medicine and Molecular Imaging from 2019-2022 and served as the President of the SNMMI Brain Imaging Council in 2022/2023.

Karina Mosci, MD is chief of the PET/CT department of the Hospital das Forças Armadas Armadas (HFA) and Hospital Santa Lucia in Brasilia-Brazil. She has focused her career in clinical practice, and is very enthusiastic about advancing nuclear medicine applications. Her passion for technology and education led her to work as a consultant and speaker for nuclear medicine and PET/CT for several years. Dr. Mosci's involvement with neuroimaging began in 2009, after a PET/CT neuroimaging fellowship at the University of Washington. She is an advocate for the development of the field through accessible education. She has organized several educational courses nationally and internationally and served as President of Imaging Brain Imaging Council at the Society of Nuclear Medicine and Molecular Imaging.

Satoshi Minoshima, MD, PhD is Professor and Anne G. Osborn Chair of the Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City. He is subspecialized in Nuclear Medicine and Molecular Imaging. He has published numerous articles, book chapters, proceedings, and abstracts and given educational lectures internationally. He invented a diagnostic statistical mapping technology that is used in more than 50 countries worldwide and discovered a very early sign of Alzheimer's disease and metabolic signature of Dementia with Lewy bodies using brain PET imaging. He served as the President of Brain Imaging Council of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), Chair of the SNMMI Scientific Program Committee, the President of the SNMMI, and the Chair of Molecular Imaging Committee of Radiological Society of North America (RSNA). He is currently serving as the Chair on the SNMMI Value Initiative and the Chair on the RSNA Research and Education Foundation Board of Trustees.

Donna Cross, PhD 是猶他大學放射學與影像科學系的副教授，擁有20年的神經影像學經驗，專注於研究神經退行性疾病和中樞神經系統疾病。她的目標是透過影像技術對神經疾病的治療和診斷選項產生重大影響。Cross博士的研究專注於創新性地使用影像技術，為基礎研究與臨床應用之間架起橋樑，並通過影像和數據分析的新應用推進生物學發現。她曾於2019年至2022年間擔任核醫學與分子影像學會科學計畫委員會的科學摘要副主席，並於2022/2023年擔任SNMMI腦影像委員會的主席。

Karina Mosci, MD 是巴西巴西利亞的武裝部隊醫院（HFA）和聖露西亞醫院的PET/CT部門主任。她的職業生涯專注於臨床實踐，並對推進核醫學應用充滿熱情。她對技術和教育的熱愛使她在核醫學和PET/CT領域擔任顧問和演講者多年。Mosci博士於2009年在華盛頓大學完成PET/CT神經影像學的研究員計畫後，開始參與神經影像學的工作。她是推動該領域可及教育發展的倡導者，曾在國內外組織多個教育課程，並擔任核醫學與分子影像學會的影像腦影像委員會主席。

Satoshi Minoshima, MD, PhD 是猶他大學放射學與影像科學系的教授及Anne G. Osborn講座教授。他專精於核醫學和分子影像學，發表了大量的文章、書籍章節、會議紀錄和摘要，並在國際上進行教育講座。他發明了一種診斷統計映射技術，該技術在全球50多個國家使用，並利用腦部PET影像發現了阿茲海默症的早期徵兆及路易體癡呆的代謝特徵。他曾擔任核醫學與分子影像學會（SNMMI）腦影像委員會的主席、SNMMI科學計畫委員會的主席、SNMMI的主席，以及北美放射學會（RSNA）分子影像委員會的主席。目前，他擔任SNMMI價值倡議的主席及RSNA研究與教育基金會董事會主席。